Boehringer Ingelheim and GST prepared bring innovation to equine market
Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine marketFirst-ever veterinary stem cell medicine recommended for EU marketing authorisationArti-Cell Forte provides a unique ready-to-use solution for the treatment of equine lamenessBoehringer Ingelheim again demonstrates its commitment to continuous innovation
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news